(S1 (S (NP (NN EBV) (JJ Latent) (NN Membrane) (NN Protein) (CD 1)) (VP (VBZ Activates) (NP (NP (NP (NN Akt)) (, ,) (NP (NN NFkappaB)) (, ,) (CC and) (NP (NN Stat3))) (PP (IN in) (NP (NN B) (NN Cell) (NNS Lymphomas)))))))
(S1 (S (S (NP (NP (JJ Latent) (NN membrane) (NN protein) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN LMP1)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT the) (JJ major) (NN oncoprotein)) (PP (IN of) (NP (NP (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (JJ transgenic) (NNS mice))) (, ,) (NP (NN LMP1)) (VP (VBZ promotes) (NP (VBN increased) (NN lymphoma) (NN development)) (PP (IN by) (NP (NP (CD 12) (NN mo)) (PP (IN of) (NP (NN age))))))) (. .)))
(S1 (S (S (NP (DT This) (NN study)) (VP (VBZ reveals) (SBAR (IN that) (S (NP (NN lymphoma)) (VP (VBZ develops) (PP (IN in) (NP (NP (NN B-1a) (NNS lymphocytes)) (, ,) (NP (NP (DT a) (NN population)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NN transformation)) (PP (IN in) (NP (JJR older) (NNS mice))))))))))))))))) (. .)))
(S1 (S (S (S (NP (DT The) (NN lymphoma) (NNS cells)) (VP (VBP have) (VP (VBN deregulated) (NP (NN cell) (NN cycle) (NNS markers))))) (, ,) (CC and) (S (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NP (NN Akt)) (, ,) (NP (NN NFkappaB)) (, ,) (CC and) (NP (NN Stat3))))) (VP (VBP block) (NP (NP (DT the) (VBN enhanced) (NN viability)) (PP (IN of) (NP (NP (NN LMP1) (JJ transgenic) (NNS lymphocytes)) (CC and) (NP (NN lymphoma) (NNS cells))))) (ADVP (FW in) (FW vitro))))) (. .)))
(S1 (S (S (NP (NN Lymphoma) (NNS cells)) (VP (VP (VBP are) (ADJP (JJ independent) (PP (IN of) (NP (NP (NN IL4/Stat6) (NN signaling)) (PP (IN for) (NP (NP (NN survival)) (CC and) (NP (NN proliferation)))))))) (, ,) (CC but) (VP (VBP have) (NP (ADJP (RB constitutively) (VBN activated)) (NN Stat3) (NN signaling))))) (. .)))
(S1 (S (S (NP (DT These) (JJ same) (NNS targets)) (VP (VBP are) (ADVP (RB also)) (VP (VBN deregulated) (PP (IN in) (NP (NP (JJ wild-type) (NN B-1a) (NNS lymphomas)) (SBAR (WHNP (WDT that)) (S (VP (VBP arise) (ADVP (RB spontaneously)) (PP (IN through) (NP (NN age) (NN predisposition))))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NP (NN Akt)) (, ,) (NP (NN NFkappaB)) (, ,) (CC and) (NP (NN Stat3))) (NNS pathways)) (VP (MD may) (VP (VB serve) (PP (IN as) (NP (NP (JJ effective) (NNS targets)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ EBV-associated) (NN B) (NN cell) (NNS lymphomas))))))))))))) (. .)))
